CRSP 8-K 2026-01-12

CRISPR Therapeutics AG (CRSP) 8-K dated 2026-01-12 — accession 0001193125-26-009880.

CRISPR Therapeutics AG (CRSP) is a biotechnology company listed on US.

CRISPR Therapeutics AG filed a 8-K on 2026-01-12. Accession 0001193125-26-009880.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRSP revenue for 2025-12-31 was $3.5M. Net income was -$581.6M. Revenue was down 90.6% from 2024-12-31 to 2025-12-31. CRSP currently screens at market cap $5.42B.

Not investment advice. The CRSP SEC hub lists recent forms. The stock page is the research view.